bluebird bio Appoints World Leading Experts to Inaugural Scientific Advisory Board

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, an emerging leader in the development of innovative gene therapies for severe genetic disorders, today announced the appointment of leading experts to its newly formed scientific advisory board. The newly appointed SAB will serve as a strategic resource to bluebird bio as it continues to develop therapies for severe genetic disorders.

Back to news